Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study

IF 7.9 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Orit Kaidar-Person , André Pfob , Vincenzo Valentini , Marianne Aznar , Andre Dekker , Icro Meattini , Jana de Boniface , David Krug , Maria Joao Cardoso , Giuseppe Curigliano , Peter Dubsky , Philip Poortmans
{"title":"Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study","authors":"Orit Kaidar-Person ,&nbsp;André Pfob ,&nbsp;Vincenzo Valentini ,&nbsp;Marianne Aznar ,&nbsp;Andre Dekker ,&nbsp;Icro Meattini ,&nbsp;Jana de Boniface ,&nbsp;David Krug ,&nbsp;Maria Joao Cardoso ,&nbsp;Giuseppe Curigliano ,&nbsp;Peter Dubsky ,&nbsp;Philip Poortmans","doi":"10.1016/j.breast.2025.104537","DOIUrl":null,"url":null,"abstract":"<div><div>Artificial intelligence (AI) is being incorporated in several breast cancer care domains, including for radiation therapy (RT). Herein we provide a review about AI for the management and planning of RT for breast cancer, which is part of the Toolbox-3 project's multidisciplinary Delphi study, including a literature review of studies related to the topic raised by the Delphi questionnaire. Our review shows that available evidence mainly consists of small single institutional studies, often at least partly supported by commercial companies. Current studies suffer from a lack of transparency regarding how these systems were developed, the information they are based on, the algorithms used, and potential proprietary issues. This review provides a critical inter- and multidisciplinary assessment of existing systems to help us in guiding development and utilisation of AI-based tools in the field of radiation oncology. As medical professional users, we must remain vigilant and continue to improve our personal experience and knowledge that serves as the \"ground truth\". Employing AI required a critical mindset, particularly in medical applications which may influence the lives of our patients.</div></div>","PeriodicalId":9093,"journal":{"name":"Breast","volume":"83 ","pages":"Article 104537"},"PeriodicalIF":7.9000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960977625005545","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial intelligence (AI) is being incorporated in several breast cancer care domains, including for radiation therapy (RT). Herein we provide a review about AI for the management and planning of RT for breast cancer, which is part of the Toolbox-3 project's multidisciplinary Delphi study, including a literature review of studies related to the topic raised by the Delphi questionnaire. Our review shows that available evidence mainly consists of small single institutional studies, often at least partly supported by commercial companies. Current studies suffer from a lack of transparency regarding how these systems were developed, the information they are based on, the algorithms used, and potential proprietary issues. This review provides a critical inter- and multidisciplinary assessment of existing systems to help us in guiding development and utilisation of AI-based tools in the field of radiation oncology. As medical professional users, we must remain vigilant and continue to improve our personal experience and knowledge that serves as the "ground truth". Employing AI required a critical mindset, particularly in medical applications which may influence the lives of our patients.
人工智能在乳腺癌放疗中的应用:来自工具箱联盟德尔菲研究的见解
人工智能(AI)正在被纳入几个乳腺癌护理领域,包括放射治疗(RT)。在此,我们对人工智能在乳腺癌放疗管理和计划中的应用进行了综述,这是工具箱3项目多学科德尔菲研究的一部分,包括对德尔菲问卷提出的主题相关研究的文献综述。我们的综述显示,现有的证据主要由小型的单一机构研究组成,通常至少部分得到商业公司的支持。目前的研究在这些系统是如何开发的、它们所基于的信息、使用的算法和潜在的专有问题方面缺乏透明度。本综述提供了对现有系统的重要的跨学科和多学科评估,以帮助我们指导放射肿瘤学领域中基于人工智能的工具的开发和利用。作为医疗专业用户,我们必须保持警惕,不断提高我们作为“基本真理”的个人经验和知识。使用人工智能需要批判性思维,特别是在可能影响患者生命的医疗应用中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Breast
Breast 医学-妇产科学
CiteScore
8.70
自引率
2.60%
发文量
165
审稿时长
59 days
期刊介绍: The Breast is an international, multidisciplinary journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信